Company intelligence / Profile preview

V2M Capital

Palm Beach Gardens, Florida, United States

Ownership: Private
Employees: ~3
Development stage: Other

Overview

V2M Capital is a private investment firm focused on public life sciences companies developing innovative products for critical or life-threatening unmet medical needs. The firm describes its strategy as investing in undervalued healthcare and life science companies whose products may materially improve or save patients' lives. V2M is not a drug developer, CRO, or operating biotech company; rather, it manages life sciences-focused investment vehicles, including the V2M Life Sciences fund. The firm is led by founder and chief investment officer Misha Petkevich and traces its roots to BladeRock Capital, a predecessor firm co-founded in 2005.

Industry: Investors

Beyond the preview

Go deeper on V2M Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on V2M Capital.

Explore the full profile